Pharma success increasingly depends on proving value

05/15/2013 | PharmaTimes (U.K.)

A drug's success in the marketplace increasingly depends on the drugmaker's ability to prove value and additional benefit over existing pharmaceuticals, yet many drugmakers still take a blockbuster approach to development, an international survey by Camelot Management Consultants finds.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief: